Strengthening Technological Competitiveness through New Technology Adoption and Joint Research
First written in FY2023. 3 of 4 entries say "Advanced", first in FY2025. Latest entry: 2026-08-05.
49 other companies' latest entry also says "Advanced".
- FY2025AdvancedAnnual report
「In 2025, we established a new Research Strategy Department as an internal organization, which enabled the active technology development described above. By having the department oversee company-wide research strategy, intellectual property strategy and alliance management, we filed 6 patent applications, including Perfusio and AISLAR, while also revisiting the scope of our intellectual property and business to avoid missing revenue opportunities.」
The company established a Research Strategy Department responsible for research strategy, intellectual property strategy and alliance management. This led to 6 patent applications, including Perfusio and AISLAR. - FY2023First statedAnnual report
「We seek to strengthen our technological competitiveness by feeding knowledge accumulated through joint drug-discovery research with pharmaceutical companies and our own research back into our platform technology, while actively incorporating new technologies through joint research with universities and business alliances with other companies to expand the platform’s functionality.」
The company plans to feed knowledge gained through joint research, in-house research and alliances with universities and other companies back into the platform to expand its technological capabilities.